ABI Accelerates Next-Gen Sequencer Launch; Fiscal Q4 Sales Rise 7 Percent | GenomeWeb
NEW YORK (GenomeWeb News) — Applied Biosystems today said that it is accelerating by at least three months the formal launch of its SOLiD next-generation DNA sequencer.
 
The company also said that fiscal fourth-quarter revenues rose 7 percent as R&D spending surged 15.6 percent and profit grew 14.5 percent.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.